In 42 patients who received neoadjuvant chemotherapy, the expression level of COL4A1 in the tumor, as assessed by immunohistochemistry, was not associated with age (Table 2), but was highly positively correlated with stage status (P=0.046). Here, COL4A1 is linked to neoplasm.